European Medical Solutions (EBR:ALEMS)
Belgium · Delayed Price · Currency is EUR 5.00
-0.48 (-8.76%)
Oct 30, 2025, 10:45 AM CET
EBR:ALEMS Market Cap
EBR:ALEMS has a market cap or net worth of €23.19 million as of October 30, 2025. Its market cap has decreased by -16.30% in one year.
Market Cap
23.19M
Enterprise Value
39.61M
Revenue
49.47M
Ranking
n/a
PE Ratio
19.77
Stock Price
€5.00
Market Cap Chart
Since May 11, 2016, EBR:ALEMS's market cap has decreased from 86.09M to 23.19M, a decrease of -73.06%. That is a compound annual growth rate of -12.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 23.19M | -8.67% |
| Dec 31, 2024 | 25.39M | -27.47% |
| Dec 29, 2023 | 35.01M | -57.73% |
| Dec 30, 2022 | 82.82M | 1,588.91% |
| Dec 31, 2021 | 4.90M | 0.90% |
| Dec 31, 2020 | 4.86M | -28.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| May 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 46.21B |
| argenx SE | 42.96B |
| Financière de Tubize | 10.19B |
| Fagron NV | 1.53B |
| Ion Beam Applications | 323.69M |
| Onward Medical | 198.85M |
| Nyxoah | 180.63M |
| Hyloris Pharmaceuticals | 151.20M |